MENU
AVXL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Anavex Life Sciences (AVXL) Earnings Date & Reports

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

AVXL is expected to report earnings to fall 11.37% to -14 cents per share on December 22

Anavex Life Sciences AVXL Stock Earnings Reports
Q3'25
Est.
$-0.14
Q2'25
Missed
by $0.01
Q1'25
Beat
by $0.02
Q4'24
Beat
by $0.02
Q3'24
Beat
by $0.02
The last earnings report on August 12 showed earnings per share of -15 cents, missing the estimate of -14 cents. With 950.54K shares outstanding, the current market capitalization sits at 854.21M.
View a ticker or compare two or three
AVXL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. AVXL showed earnings on August 12, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of innovative drug compounds

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
630 5th Avenue
Phone
+1 844 689-3939
Employees
40
Web
https://www.anavex.com